<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DAE7F8F7-1B15-47CA-844D-044010E02914"><gtr:id>DAE7F8F7-1B15-47CA-844D-044010E02914</gtr:id><gtr:name>University of Hasselt</gtr:name><gtr:address><gtr:line1>Campus Diepenbeek</gtr:line1><gtr:line2>Agoralaan Gebouw D</gtr:line2><gtr:line3>BE 3590</gtr:line3><gtr:line4>Diepenbeek</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C6D419CE-BBD7-4220-BFEC-AB98637B78E2"><gtr:id>C6D419CE-BBD7-4220-BFEC-AB98637B78E2</gtr:id><gtr:name>Pharmatics Limited</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E3B20713-956F-4D17-9AF7-B561CCBAE326"><gtr:id>E3B20713-956F-4D17-9AF7-B561CCBAE326</gtr:id><gtr:name>University of Bologna</gtr:name><gtr:address><gtr:line1>Via Irnerio 46</gtr:line1><gtr:postCode>40126</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/BCAE40A9-5A38-4B94-A742-AEDAD7D4681F"><gtr:id>BCAE40A9-5A38-4B94-A742-AEDAD7D4681F</gtr:id><gtr:name>Leiden University Medical Centre</gtr:name><gtr:address><gtr:line1>PO Box 9600</gtr:line1><gtr:line4>Leiden</gtr:line4><gtr:line5>NL-2300 RC</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>School of Clinical Sciences</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DAE7F8F7-1B15-47CA-844D-044010E02914"><gtr:id>DAE7F8F7-1B15-47CA-844D-044010E02914</gtr:id><gtr:name>University of Hasselt</gtr:name><gtr:address><gtr:line1>Campus Diepenbeek</gtr:line1><gtr:line2>Agoralaan Gebouw D</gtr:line2><gtr:line3>BE 3590</gtr:line3><gtr:line4>Diepenbeek</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C6D419CE-BBD7-4220-BFEC-AB98637B78E2"><gtr:id>C6D419CE-BBD7-4220-BFEC-AB98637B78E2</gtr:id><gtr:name>Pharmatics Limited</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E3B20713-956F-4D17-9AF7-B561CCBAE326"><gtr:id>E3B20713-956F-4D17-9AF7-B561CCBAE326</gtr:id><gtr:name>University of Bologna</gtr:name><gtr:address><gtr:line1>Via Irnerio 46</gtr:line1><gtr:postCode>40126</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/BCAE40A9-5A38-4B94-A742-AEDAD7D4681F"><gtr:id>BCAE40A9-5A38-4B94-A742-AEDAD7D4681F</gtr:id><gtr:name>Leiden University Medical Centre</gtr:name><gtr:address><gtr:line1>PO Box 9600</gtr:line1><gtr:line4>Leiden</gtr:line4><gtr:line5>NL-2300 RC</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/8B655D32-2D40-4464-8752-DD206A7BC0F4"><gtr:id>8B655D32-2D40-4464-8752-DD206A7BC0F4</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>Matthew</gtr:otherNames><gtr:surname>McKeigue</gtr:surname><gtr:orcidId>0000-0002-5217-1034</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/969BE365-A2B6-41F9-8980-E33BD3F4265F"><gtr:id>969BE365-A2B6-41F9-8980-E33BD3F4265F</gtr:id><gtr:firstName>Amos</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Storkey</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0800604"><gtr:id>7F817D77-B826-44C0-8D46-42571D885A08</gtr:id><gtr:title>Development of Bayesian methods for genetic epidemiology</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0800604</gtr:grantReference><gtr:abstractText>Understanding how the information encoded in our genes affects our health will, in the long run, lead to new ways of preventing and treating disease. It is now possible to measure hundreds of thousands of genetic variants in people who take part in large-scale medical research projects such as the UK Biobank. The problem is how to analyse these measurements so as to learn how genes and environmental factors interact. Conventional methods of analysing data are not adequate for such complex problems. We plan to develop new ways of analysing data, drawing on methods developed in other fields of research such as physics and computer science. These methods will be applied to analyse information obtained from people who have participated in large-scale studies of genetics and health. To test these methods, we shall apply them to a study of Scottish cancer patients compared with healthy individuals, and to studies of remote isolated populations such as Orkney islanders.</gtr:abstractText><gtr:technicalSummary>This project aims to tackle several problems in genetic epidemiology that are intractable to classical statistical methods, using a common set of methods and tools that exploit recent advances in machine learning, computer science and probabilistic inference. 
1.Analysis of genome-wide association studies using tag SNP arrays in combination with HapMap data, to impute HapMap haplotypes and test for association at both typed and untyped loci. This will build on the program HAPMIXMAP already developed, which combines Bayesian modelling with classical hypothesis tests. To overcome the limitations of current approaches based on fixed-dimensional hidden Markov models, we plan to evaluate alternative approaches based on Dirichlet process mixtures and variational Bayes approximations.
2.Analysis of ?mendelian randomization? studies in which genotype is used as an ?instrumental variable? to infer a causal effect of an intermediate phenotype on disease risk. This will be developed using a freely-available program (JAGS) for Bayesian inference in graphical models. 
3.Analysis of gene-gene interactions, gene-environment interactions and pathways through which genotype and environmental factors influence intermediate phenotypes and disease outcomes. This will use a comparatively novel approach - variational Bayes approximation combined with automatic relevance determination - to learn the structure of graphical models. Development will be based on extending the freely-available VIBES package1? for variational Bayes inference, but we shall also evaluate a commercial package (INFER.NET) that is expected to be available soon. 
4.Analysis of genome-wide association studies in isolated populations, exploiting both association and haplotype sharing through cryptic relatedness. For this we plan to develop approaches based on hidden Markov Dirichlet process models, with inference using either MCMC or variational Bayes approximations. 
Two different Bayesian learning algorithms will be used: Markov chain Monte Carlo simulation (MCMC) to sample the posterior of a specified model, and variational Bayes approximation with automatic relevance determination where the object is to learn model structure.</gtr:technicalSummary><gtr:fund><gtr:end>2012-03-15</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-03-16</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>317659</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pharmatics Limited</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Pharmatics: predictions from omics data (part of MIMOmics)</gtr:description><gtr:id>5209142C-A49D-43C9-9653-FD3C0194D4C3</gtr:id><gtr:impact>The collaboration has led to FP7 MIMOmics and MRC MATURA funding. Pharmatics will provide benefits in kind to MATURA.</gtr:impact><gtr:partnerContribution>Advised on the choice of machine learning methods and algorithms useful for predictions from high-dimensional omics data.</gtr:partnerContribution><gtr:piContribution>Participated in two joint FP7 applications. Advised on applications of stratified/personalized medicine.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Human Genetics Unit</gtr:department><gtr:description>Analysis of ORCADES study and other EUROSPAN studies of population isolates</gtr:description><gtr:id>81854223-6303-41B0-9F3E-E6F0B643E205</gtr:id><gtr:impact>paper in press see section 2</gtr:impact><gtr:partnerContribution>Access to datasets with genome-wide genotype data and extensive phenotypic biomarkers</gtr:partnerContribution><gtr:piContribution>Development of methods to infer causal relationships between biomarkers and outcomes</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wellcome Trust Centre for Human Genetics</gtr:department><gtr:description>Inference of causal effects of gene expression levels on quantitative traits in heterogeneous stocks of mice</gtr:description><gtr:id>74D9286E-8567-4A88-98B6-8EDAC2F9AFD4</gtr:id><gtr:impact>Two papers published so far in machine learning journals. A manuscript for a biomedical readership is in preparation. Disciplines involved: psychiatric genetics, statistical genetics, machine learning (a subdivision of computer science)</gtr:impact><gtr:partnerContribution>Working closely with us on analysis and interpretation of studies of heterogeneous stocks of mice typed for multiple quantitative traits and with gene expression measurements in liver, lung and hippocampus. This has allowed us to test the SPIV program</gtr:partnerContribution><gtr:piContribution>We have developed methods that exploit genetic variation for inference of causality, as described elsewhere in this report</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bologna (Universit? di Bologna UNIBO)</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Pharmatics: predictions from omics data (part of MIMOmics)</gtr:description><gtr:id>F9D855E1-FCD5-4BC9-AD0D-F386D89CEA84</gtr:id><gtr:impact>The collaboration has led to FP7 MIMOmics and MRC MATURA funding. Pharmatics will provide benefits in kind to MATURA.</gtr:impact><gtr:partnerContribution>Advised on the choice of machine learning methods and algorithms useful for predictions from high-dimensional omics data.</gtr:partnerContribution><gtr:piContribution>Participated in two joint FP7 applications. Advised on applications of stratified/personalized medicine.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Hasselt</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>Pharmatics: predictions from omics data (part of MIMOmics)</gtr:description><gtr:id>3312E7A4-5DDF-4611-8AAD-B55CD9C2A9D0</gtr:id><gtr:impact>The collaboration has led to FP7 MIMOmics and MRC MATURA funding. Pharmatics will provide benefits in kind to MATURA.</gtr:impact><gtr:partnerContribution>Advised on the choice of machine learning methods and algorithms useful for predictions from high-dimensional omics data.</gtr:partnerContribution><gtr:piContribution>Participated in two joint FP7 applications. Advised on applications of stratified/personalized medicine.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leiden University Medical Center (LUMC)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Pharmatics: predictions from omics data (part of MIMOmics)</gtr:description><gtr:id>B0CE2D8F-271D-45BF-B7DC-994E80C35960</gtr:id><gtr:impact>The collaboration has led to FP7 MIMOmics and MRC MATURA funding. Pharmatics will provide benefits in kind to MATURA.</gtr:impact><gtr:partnerContribution>Advised on the choice of machine learning methods and algorithms useful for predictions from high-dimensional omics data.</gtr:partnerContribution><gtr:piContribution>Participated in two joint FP7 applications. Advised on applications of stratified/personalized medicine.</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Pleiotropy-2011</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>5C312601-3180-4009-AC96-94E94A44831D</gtr:id><gtr:impact>The work on genetic similarities between complex traits (pleiotropy) quantified by using probabilistic methods (our AJHG paper) was covered in national media, including The Times (12/2011), The Herald (12/2011), The Scotsman (12/2011), and the BBC website.

Enquiries from general public; enquiries from researchers specializing in quantitative disciplines and interested in starting collaborations. Contact from Nature Review Genetics to highlight the result as an important contribution.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pharmatics-2011</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>9B542E79-6E19-4B45-BBFD-1449850AE514</gtr:id><gtr:impact>Press conference response to local media (including the Scotsman and various online resources) that followed the announcement that out pre-spin out company, Pharmatics' Ltd, was declared the overall winner of 2012 BioQuarter Innovation Competition.

Inquiries from a London-based venture capitalist. Inquiries from a German-based research group regarding Pharmatics' interest in becoming an SME partner in an EU grant application on machine learning for personalized medicine. Participation in 2 submitted EU-FP7 grant applications.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Industry-2011</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>26715A1C-BE38-40D4-A53D-48127997D022</gtr:id><gtr:impact>Four presentations to different groups of industry members, including the heads of UK-based RnD departments of two companies listed on FTSE100.

An initiated pilot study involving a subsidiary of one of the FTSE100 companies -- further details cannot be disclosed at this stage due to an NDA.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>SUMMIT programme on biomarkers for diabetic complications (29m euros across 23 participants)</gtr:description><gtr:end>2015-02-02</gtr:end><gtr:fundingOrg>European Commission (EC)</gtr:fundingOrg><gtr:id>19472C7B-1437-48C2-AD42-02A3670E76AD</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>131924</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Stratified Medicine Initiative: Maximising Therapeutic Utility for Rheumatoid Arthritis</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>BFBCB688-522A-4C66-9788-FD02A1E5DA2D</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>We have developed an algorithm for modelling sparse covariance structures that include both observed and unobserved variables. This has wide application not only in biomedical research but in other fields such as financial modellling. We have initiated consultation within our institute on what forms of intellectual property protection (apart from copyright on software) may be appropriate</gtr:description><gtr:id>D825ECA0-196A-45DA-9CDF-5F416A5D6A52</gtr:id><gtr:impact>Invitations to present the results at industry meetings. A non-profit pilot project with a subsidiary of a FTSE100-listed company using their proprietary dataset.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:protection>Copyrighted (e.g. software)</gtr:protection><gtr:title>Sparse Latent Inverse Covariance Estimation (SLICE)</gtr:title><gtr:yearProtectionGranted>2011</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Software for reducing a high-dimensional vector of predictive factors (such as -omics) to a lower-dimensional subset JOINTLY predictive of the outcome.</gtr:description><gtr:id>76D17DBB-BD15-4495-ACCC-C0586795B020</gtr:id><gtr:impact>Collaboration with groups in Pavia, Padova on the SUMMIT project and a group in WTHG Oxford for our joint analysis of mouse data.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Robust Adaptive FeaTure selection (RAFT)</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed an R software package that implements the &amp;quot;long-range phasing&amp;quot; method for inference of shared haplotypes in population isolates, originally described by Kong et al. Our method improves on the original in that it does not require the genome to be partitioned into short segments, which may lose information, and does not rely on pedigree data to stitch together the inferred haplotypes</gtr:description><gtr:id>CB38A7FA-2F0B-4572-90A1-9C18899669BF</gtr:id><gtr:impact>This software has been used by our collaborators in the MRC Human Genetics Unit to select optimal subsets of individuals for exon resequencing. We are also exploring its use to detect effects of rare alleles on shared haplotypes in isolates.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Long-range phasing&quot; for inference of shared haplotypes in population isolates</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>This software tool can be used with genotype-phenotype data to infer causal relationships between phenotypic biomarkers and outcome.</gtr:description><gtr:id>01FB92D2-ED92-4F18-A4B1-B70A88163F5E</gtr:id><gtr:impact>We expect this tool to have wide use for validating biomarkers as therapeutic targets or as surrogate endpoints in clinical trials.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>SParse Instrumental Variables software for inference of causal biomarkers (SPIV)</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Pharmatics Ltd</gtr:companyName><gtr:description>Pharmatics is a startup company developing intelligent software and providing data mining services to industries. We are developing software that can be used to validate causal pathways that may contain therapeutic targets, and identify biomarkers that can be used as surrogate end-points in Phase 2 trials. We are also developing tools for prediction of individual response from high-dimensional -omic measurements. More details are given at www.pharmaticsltd.co.uk</gtr:description><gtr:id>353235F7-C8CA-493F-91D3-8DCAB798ABD6</gtr:id><gtr:impact>Pharmatics is a young RnD company. It is working on a pilot project with a company listed on FTSE100. In July 2011, Pharmatics was announced the overall winner of BioQuarter Innovation Competition 2011, showing a potential for becoming one of the most promising young bio-medical companies in Scotland.</gtr:impact><gtr:url>http://www.pharmaticsltd.com/</gtr:url><gtr:yearCompanyFormed>2011</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/722DC964-3F91-4B28-A527-F95E48525FE6"><gtr:id>722DC964-3F91-4B28-A527-F95E48525FE6</gtr:id><gtr:title>Instrumental variable estimation of the causal effect of plasma 25-hydroxy-vitamin D on colorectal cancer risk: a mendelian randomization analysis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ddf6086ff1060ed1c3c1158b9e0085f5"><gtr:id>ddf6086ff1060ed1c3c1158b9e0085f5</gtr:id><gtr:otherNames>Theodoratou E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D0A9D549-E980-4DC6-B397-FE94B9C991EF"><gtr:id>D0A9D549-E980-4DC6-B397-FE94B9C991EF</gtr:id><gtr:title>Diet, environmental factors, and lifestyle underlie the high prevalence of vitamin D deficiency in healthy adults in Scotland, and supplementation reduces the proportion that are severely deficient.</gtr:title><gtr:parentPublicationTitle>The Journal of nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/70acb76c21dd6edc430aff474b546cb1"><gtr:id>70acb76c21dd6edc430aff474b546cb1</gtr:id><gtr:otherNames>Zgaga L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3166</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/77097F89-88DD-4D46-A54E-BE1432236DAF"><gtr:id>77097F89-88DD-4D46-A54E-BE1432236DAF</gtr:id><gtr:title>Model selection approach suggests causal association between 25-hydroxyvitamin D and colorectal cancer.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/70acb76c21dd6edc430aff474b546cb1"><gtr:id>70acb76c21dd6edc430aff474b546cb1</gtr:id><gtr:otherNames>Zgaga L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C080558C-C68F-426E-9439-66327663E7D3"><gtr:id>C080558C-C68F-426E-9439-66327663E7D3</gtr:id><gtr:title>The association of dietary intake of purine-rich vegetables, sugar-sweetened beverages and dairy with plasma urate, in a cross-sectional study.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/70acb76c21dd6edc430aff474b546cb1"><gtr:id>70acb76c21dd6edc430aff474b546cb1</gtr:id><gtr:otherNames>Zgaga L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B59F153F-0407-4FCA-8A29-FDDDE8A0B70F"><gtr:id>B59F153F-0407-4FCA-8A29-FDDDE8A0B70F</gtr:id><gtr:title>Discriminative Mixtures of Sparse Latent Fields for Risk Management</gtr:title><gtr:parentPublicationTitle>Journal of Machine Learning Research W&amp;CP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8845524505e844005b00c61e1223d1ae"><gtr:id>8845524505e844005b00c61e1223d1ae</gtr:id><gtr:otherNames>Agakov</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/85C503FC-20FB-4C91-A0DF-406F14766AA6"><gtr:id>85C503FC-20FB-4C91-A0DF-406F14766AA6</gtr:id><gtr:title>Inference of identity by descent in population isolates and optimal sequencing studies.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/47c4c8256dd4a034d1596172c74ce2b0"><gtr:id>47c4c8256dd4a034d1596172c74ce2b0</gtr:id><gtr:otherNames>Glodzik D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EBDC49D0-B175-4295-8E93-B1959F440B60"><gtr:id>EBDC49D0-B175-4295-8E93-B1959F440B60</gtr:id><gtr:title>Inference of causal relationships between biomarkers and outcomes in high dimensions</gtr:title><gtr:parentPublicationTitle>Journal of Systemics, Cybernetics, and Informatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8aedbd7bed27505348c6feee0b2836e0"><gtr:id>8aedbd7bed27505348c6feee0b2836e0</gtr:id><gtr:otherNames>Agakov, Felix</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BFE6C822-7517-4D7B-B7C1-1B60340535C6"><gtr:id>BFE6C822-7517-4D7B-B7C1-1B60340535C6</gtr:id><gtr:title>Abundant pleiotropy in human complex diseases and traits.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/06c08c7c6435b79d4eb70dcdb9fce4a5"><gtr:id>06c08c7c6435b79d4eb70dcdb9fce4a5</gtr:id><gtr:otherNames>Sivakumaran S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/15494135-BA90-4EE8-8239-4ECC5B5BCD9D"><gtr:id>15494135-BA90-4EE8-8239-4ECC5B5BCD9D</gtr:id><gtr:title>Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3982d000592c7bb3d227998a20f0c93b"><gtr:id>3982d000592c7bb3d227998a20f0c93b</gtr:id><gtr:otherNames>Ansari M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DA7A23DE-9A5E-4D9C-9A44-A198E737A452"><gtr:id>DA7A23DE-9A5E-4D9C-9A44-A198E737A452</gtr:id><gtr:title>Sparse Instrumental Variables (SPIV) for genome-wide studies</gtr:title><gtr:parentPublicationTitle>Advances in Neural Information Processing Systems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8aedbd7bed27505348c6feee0b2836e0"><gtr:id>8aedbd7bed27505348c6feee0b2836e0</gtr:id><gtr:otherNames>Agakov, Felix</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5A98DCF0-86C3-440F-A8D5-F89C2E09DC98"><gtr:id>5A98DCF0-86C3-440F-A8D5-F89C2E09DC98</gtr:id><gtr:title>Bayesian methods for instrumental variable analysis with genetic instruments ('Mendelian randomization'): example with urate transporter SLC2A9 as an instrumental variable for effect of urate levels on metabolic syndrome.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ad949ca6e0859665c29d747b11a2abff"><gtr:id>ad949ca6e0859665c29d747b11a2abff</gtr:id><gtr:otherNames>McKeigue PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800604</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>FB395309-E202-4FE8-87B0-041A3D72D4D4</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.5  Research design and methodologies (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>